List view / Grid view
29 February 2016 | By Victoria White
ProTx-II, a peptide toxin found within the venom of the Peruvian green velvet tarantula, has a high potency and selectivity to inhibit the pain sensation receptor...
26 February 2016 | By Victoria White
Regen has recently filed two patent applications covering the molecular pathways activated by NR2F6 silencing...
26 February 2016 | By Victoria White
Researchers have developed a targeted substance that blocks the pathogenic function of an enzyme that is partly responsible for Alzheimer’s disease without affecting its other vital functions...
26 February 2016 | By Victoria White
A single monoclonal antibody isolated from a human survivor of Ebola virus completely protected monkeys from lethal infection with the virus...
25 February 2016 | By Victoria White
Adaptive therapy is based on evolutionary principals and aims to keep resistant cells in check by maintaining a population of chemo-sensitive cells...
25 February 2016 | By Victoria White
Data from the preclinical study support continued investigation of GS-9620 as part of an HIV eradication strategy…
24 February 2016 | By Victoria White
A study has revealed that pancreatic cancer is actually four separate diseases, each with different genetic triggers and survival rates, paving the way for more accurate diagnoses and treatments...
24 February 2016 | By Victoria White
Using a modified version of troponin C, researchers showed it can enhance or therapeutically preserve heart function and cardiovascular performance in mice...
24 February 2016 | By Victoria White
Researchers have discovered that the protein cathelicidin antimicrobial peptide helps the pancreas regenerate and produce insulin...
Avacta is to develop inhibin Affimer inhibitors. Inhibition of this protein stimulates the production of greater numbers of embryos per mouse...
24 February 2016 | By Victoria White
Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that uses DNA origami packaging...
23 February 2016 | By Victoria White
In a highly relevant non-human primate model TYG100 was able to induce a strong and clinically relevant immune response...
23 February 2016 | By Victoria White
Plasticell and Pierre Fabre are to work together to discover plant-based products that enhance the metabolic function of brown adipose tissue...
23 February 2016 | By Victoria White
Given the key role of epigenetics in all tumour types, Desktop Genetics' research has wide potential applications across all histological types of cancer...
22 February 2016 | By Katie Sadler
Pherecydes Pharma has announced the appointment of Guy-Charles Fanneau de La Horie, MBA as its new Chief Executive Officer.
